You're watching...
CDC: 91 cases of rare fungal meningitis surface
Details
-
Description
Jonathan Serrie reports from Atlanta
- Duration 2:01
- Date Oct 8, 2012
You're watching...
Jonathan Serrie reports from Atlanta
Also in this playlist...
Auto-advance: ON
Auto-advanceThis transcript is automatically generated
Well dramatic jump in the number of cases of the rare fungal meningitis.
Is an outbreak now sweeping the US.
According to the Centers for Disease Control there are now 91 cases.
Across nine states they're linked to contaminated steroid injections commonly used to treat back pain.
At least seven people are dead Jonathan Serrie is live now in Atlanta -- hi Jonathan so how widespread is this.
A good morning -- again so far the cases reported are in the eastern half of the country want to -- you this map again the CDC is confirmed 981 cases associated with this meningitis outbreak in vis nine states and a total of seven deaths.
Have been reported across four states those states are Michigan.
Tennessee Maryland and Virginia -- -- The source Jonathan of the outbreak.
Well this is a very rare form of meningitis -- -- other forms bacterial and viral this particular form is not spread.
From person to person instead federal health officials.
Have traced it.
To -- -- fungus and that they believe that somehow medication.
That was compounded at the New England compounding senator a specialty pharmacy in Massachusetts somehow became contaminated.
With this fungus the patients getting sick.
Had all received epidural injections for -- lower back pain at healthcare facilities that had received shipments of steroids from that pharmacy sometime between July and September we have another map to show you indicating -- -- at least 23 states received the shipments in question.
Now because this particular form of meningitis.
Has a long incubation period can last anywhere from.
One to four weeks even though this particular medication.
Had then we're called earlier we maybe see some additional cases as we go in until late October -- -- troubling story -- Jonathan Serrie.